HEAVY SOLUTION NUPERCAINE Drug Patent Profile
✉ Email this page to a colleague
When do Heavy Solution Nupercaine patents expire, and when can generic versions of Heavy Solution Nupercaine launch?
Heavy Solution Nupercaine is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in HEAVY SOLUTION NUPERCAINE is dibucaine hydrochloride. Additional details are available on the dibucaine hydrochloride profile page.
Summary for HEAVY SOLUTION NUPERCAINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HEAVY SOLUTION NUPERCAINE at DailyMed |
US Patents and Regulatory Information for HEAVY SOLUTION NUPERCAINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | HEAVY SOLUTION NUPERCAINE | dibucaine hydrochloride | INJECTABLE;INJECTION | 006203-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |